FDA Approves Zyn Pouches For Sale As Less Harmful Alternative To Cigarettes
The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.
Buy Rating for Philip Morris: Strategic Positioning and FDA Approval of ZYN Pouches
Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...
Hosted on MSN17d
Philip Morris closes on the sale of Vectura Group
Shares of Philip Morris International edged 0.4% higher in premarket action on Thursday to $120.80 vs. the 52-week range of $87.82 to $134.15. The dividend yield for new buyers of the stock is 4. ...
Philip Morris: Growth Potential in Smoke-Free Product Portfolio Fuels Buy Rating
Morgan Stanley analyst Eric Serotta has maintained their bullish stance on PM stock, giving a Buy rating on January 10.Stay Ahead of the ...
Reuters1mon
Philip Morris International Inc
Philip Morris to pay $1.2 mln to settle probe into ... nicotine pouches The sale of single-use vapes will be banned in England from June next year, the British government said on Thursday, seeking ...
Philip Morris International Inc. (NYSE:PM) Shares Sold by First Hawaiian Bank
First Hawaiian Bank decreased its position in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by 4.8% ...
Seeking Alpha17d
Philip Morris closes on the sale of Vectura Group
Philip Morris International Inc. (NYSE:PM) announced on Thursday that it completed the previously announced sale of its subsidiary Vectura Group Ltd. to Molex Asia Holdings Ltd. The deal terms ...